Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Therapeutic Challenges of Huntington's Disease in Guinea: Study of HD Confirmed Cases in a Country with Limited Resources

Author:Carlos Othon, GUELNGAR   Muthinja, Mendi Julianne   Rizig, Mie   Cisse, Abass Fode   cisse, Amara   

Session Name:P2: Movement Disorders: Huntington's Disease and Chorea 2  

Topic:Movement Disorders  

Program Number:P2.013  

Author Institution:National Ignace Deen Hospital, University of Conakry, Conakry, Guinea, Conakry, Guinea  Huntington disease Africa, Nairobi, Kenya  Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK, London, United Kingdom  

The Use of Onasemnogene-abeparvovec at 33 weeks’ gestation in Spinal Muscular Atrophy with One Copy of SMN2

Author:Ajjarapu, Aparna   Mathews, Katherine   Ramachandra, Divya   

Session Name:P2: Neuromuscular Disease: ALS, SMA, and Other Motor Neuron Disorders 1  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P2.013  

Author Institution:University of Iowa Carver College of Medicine , Iowa City , IA  Advocate Children’s Hospital, Oak Lawn , IL  

Remibrutinib Inhibits Neuroinflammation Driven by B Cells and Myeloid Cells in Preclinical Models of Multiple Sclerosis

Author:Kieseier, Bernd   Cenni, Bruno   Nuesslein-Hildesheim, Barbara   Ferrero, Enrico   Huck, Catherine   Eichlisberger, Denis   Ziehn, Marina   

Session Name:P2: MS Immunology and Basic Science  

Topic:MS and Inflammatory Disease  

Program Number:P2.013  

Author Institution:Novartis Pharma AG  Novartis Institutes for Biomedical Research